Umut Şahin

2.3k total citations · 1 hit paper
20 papers, 1.9k citations indexed

About

Umut Şahin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Umut Şahin has authored 20 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Umut Şahin's work include Ubiquitin and proteasome pathways (8 papers), Retinoids in leukemia and cellular processes (5 papers) and Peptidase Inhibition and Analysis (4 papers). Umut Şahin is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Retinoids in leukemia and cellular processes (5 papers) and Peptidase Inhibition and Analysis (4 papers). Umut Şahin collaborates with scholars based in France, Türkiye and United States. Umut Şahin's co-authors include Carl Blobel, Gisela Weskamp, Hugues de Thé, Dieter Hartmann, Paul Säftig, Hongming Zhou, Kristine Kelly, Jacques J. Peschon, Shigeki Higashiyama and Valérie Lallemand-Breitenbach and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and Blood.

In The Last Decade

Umut Şahin

20 papers receiving 1.8k citations

Hit Papers

Distinct roles for ADAM10 and ADAM17 in ectodomain sheddi... 2004 2026 2011 2018 2004 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umut Şahin France 14 1.2k 622 286 280 254 20 1.9k
David Tulasne France 32 1.3k 1.1× 451 0.7× 224 0.8× 306 1.1× 271 1.1× 73 2.4k
Maria Rosa Bani Italy 28 1.6k 1.3× 789 1.3× 304 1.1× 384 1.4× 509 2.0× 62 2.4k
Elisabetta Bianchi France 24 857 0.7× 408 0.7× 255 0.9× 698 2.5× 294 1.2× 51 1.9k
Vladislav S. Golubkov United States 26 823 0.7× 617 1.0× 299 1.0× 131 0.5× 678 2.7× 52 1.6k
W. Michael Kavanaugh United States 17 1.7k 1.4× 489 0.8× 148 0.5× 339 1.2× 151 0.6× 29 2.3k
Maria P. Arrate United States 23 1.3k 1.1× 278 0.4× 304 1.1× 291 1.0× 291 1.1× 38 1.8k
Ivo J. Huijbers Netherlands 24 954 0.8× 595 1.0× 102 0.4× 315 1.1× 281 1.1× 43 1.6k
Christel Moog‐Lutz France 23 1.3k 1.1× 409 0.7× 183 0.6× 416 1.5× 424 1.7× 32 2.0k
Neetu Gupta France 19 1.7k 1.4× 298 0.5× 244 0.9× 504 1.8× 175 0.7× 33 2.6k
Andrzej Ptasznik United States 22 767 0.6× 386 0.6× 167 0.6× 437 1.6× 137 0.5× 37 1.6k

Countries citing papers authored by Umut Şahin

Since Specialization
Citations

This map shows the geographic impact of Umut Şahin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umut Şahin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umut Şahin more than expected).

Fields of papers citing papers by Umut Şahin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umut Şahin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umut Şahin. The network helps show where Umut Şahin may publish in the future.

Co-authorship network of co-authors of Umut Şahin

This figure shows the co-authorship network connecting the top 25 collaborators of Umut Şahin. A scholar is included among the top collaborators of Umut Şahin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umut Şahin. Umut Şahin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çakar, Arman, et al.. (2023). A novel homozygous loss-of-function variant in SOD1 causing progressive spastic tetraplegia and axial hypotonia. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 24(5-6). 535–538. 6 indexed citations
2.
Mete, Bilgül, et al.. (2022). Human immunodeficiency virus type 1 impairs sumoylation. Life Science Alliance. 5(6). e202101103–e202101103. 3 indexed citations
3.
Şahin, Umut, Hugues de Thé, & Valérie Lallemand-Breitenbach. (2022). Sumoylation in Physiology, Pathology and Therapy. Cells. 11(5). 814–814. 53 indexed citations
4.
Rettel, Mandy, et al.. (2022). Sumoylation of Cas9 at lysine 848 regulates protein stability and DNA binding. Life Science Alliance. 5(4). e202101078–e202101078. 9 indexed citations
5.
Şahin, Umut, et al.. (2020). Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS Journal. 287(15). 3110–3140. 166 indexed citations
6.
Şahin, Umut, Behçet Uğur Töreyın, Sevgi Önal, et al.. (2019). Automated Segmentation of Cells in Phase Contrast Optical Microscopy Time Series Images. IYTE GCRIS Database (Izmir Institute of Technology). 1–4. 4 indexed citations
7.
Auvin, Stéphane, Gisèle Mautino, Florence Jollivet, et al.. (2019). A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells. Life Science Alliance. 2(4). e201800213–e201800213. 13 indexed citations
8.
Maretzky, Thorsten, Steven Swendeman, Gisela Weskamp, et al.. (2017). Characterization of the catalytic properties of the membrane-anchored metalloproteinase ADAM9 in cell-based assays. Biochemical Journal. 474(9). 1467–1479. 16 indexed citations
9.
Şahin, Umut, Florence Jollivet, Caroline Berthier, Hugues de Thé, & Valérie Lallemand-Breitenbach. (2016). Detection of Protein SUMOylation In Situ by Proximity Ligation Assays. Methods in molecular biology. 1475. 139–150. 11 indexed citations
10.
Hajj, Hiba El, Zeina Dassouki, Caroline Berthier, et al.. (2015). Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells. Blood. 125(22). 3447–3454. 83 indexed citations
11.
Şahin, Umut, Hugues de Thé, & Valérie Lallemand-Breitenbach. (2014). PML nuclear bodies: Assembly and oxidative stress-sensitive sumoylation. Nucleus. 5(6). 499–507. 75 indexed citations
12.
Şahin, Umut, Valérie Lallemand-Breitenbach, & Hugues de Thé. (2014). PML nuclear bodies: regulation, function and therapeutic perspectives. The Journal of Pathology. 234(3). 289–291. 49 indexed citations
13.
Şahin, Umut, Pierre Lapaquette, Alexandra Andrieux, Guilhem Faure, & Anne Dejean. (2014). Sumoylation of Human Argonaute 2 at Lysine-402 Regulates Its Stability. PLoS ONE. 9(7). e102957–e102957. 28 indexed citations
14.
Dassouki, Zeina, Umut Şahin, Hiba El Hajj, et al.. (2014). ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation. Blood. 125(3). 474–482. 57 indexed citations
15.
Şahin, Umut, Omar Ferhi, Xavier Carnec, et al.. (2014). Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication. Nature Communications. 5(1). 4187–4187. 48 indexed citations
16.
Şahin, Umut, Omar Ferhi, Marion Jeanne, et al.. (2014). Oxidative stress–induced assembly of PML nuclear bodies controls sumoylation of partner proteins. The Journal of Cell Biology. 204(6). 931–945. 176 indexed citations
17.
Şahin, Umut, Gisela Weskamp, Yufang Zheng, et al.. (2006). A Sensitive Method to Monitor Ectodomain Shedding of Ligands of the Epidermal Growth Factor Receptor. Humana Press eBooks. 327. 99–114. 49 indexed citations
18.
Şahin, Umut & Carl Blobel. (2006). Ectodomain shedding of the EGF‐receptor ligand epigen is mediated by ADAM17. FEBS Letters. 581(1). 41–44. 98 indexed citations
19.
Şahin, Umut, Gisela Weskamp, Kristine Kelly, et al.. (2004). Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. The Journal of Cell Biology. 164(5). 769–779. 811 indexed citations breakdown →
20.
Zhou, Hong-Ming, Gisela Weskamp, Valérie Chesneau, et al.. (2003). Essential Role for ADAM19 in Cardiovascular Morphogenesis. Molecular and Cellular Biology. 24(1). 96–104. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026